China
3320.HKChina Resources Pharmaceutical Group Limited Price (3320.HK)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
6,282,510,461
(0)%Revenue and Profitability
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 116,950,696,000 | 135,749,180,000 | 146,568,105,000 | 156,705,203,000 | 172,532,204,000 | 189,689,107,000 | 204,453,869,000 | 200,423,023,000 | 236,806,169,001 | 254,106,366,001 | 270,397,301,734 |
| Net Income | 2,639,517,000 | 2,645,940,000 | 2,850,076,000 | 2,821,410,000 | 3,483,036,000 | 4,037,890,000 | 3,286,419,000 | 2,778,655,929 | 3,080,673,318 | 3,500,270,000 | 3,854,247,000 |
| FCF USD | 1,106,682,000 | 798,161,006 | 4,165,601,000 | 2,401,213,000 | 3,290,826,000 | 6,730,319,000 | 3,213,545,000 | 4,058,677,000 | 8,317,569,000 | 7,542,389,000 | 12,417,171,000 |
| OCF USD | 4,102,157,000 | 3,347,871,808 | 5,988,790,000 | 4,119,647,000 | 4,857,538,000 | 8,246,965,000 | 5,254,057,000 | 6,277,176,000 | 11,220,436,000 | 10,898,714,000 | 15,549,886,000 |
Financial Health - DEBT
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 3.06 | 4.52 | 2.26 | 0.99 | 2.55 | 3.26 | 0.90 | 2.15 | 2.65 | 1.61 |
| D/E | 1.74 | 1.82 | 2.12 | 1.06 | 1.16 | 1.61 | 1.34 | 1.26 | 1.62 | 1.35 | 1.23 |
| CA/CL | 1.17 | 1.29 | 1.23 | 1.32 | 1.23 | 1.23 | 1.25 | 1.20 | 1.25 | 1.25 | 1.33 |
| TA/TL | 1.45 | 1.44 | 1.46 | 1.68 | 1.65 | 1.52 | 1.59 | 1.63 | 1.63 | 1.61 | 1.60 |
| Total Debt | 31,215,597,000 | 37,262,846,000 | 47,640,323,000 | 39,828,467,000 | 48,756,653,000 | 63,217,351,000 | 54,524,602,000 | 58,633,191,000 | 82,587,580,000 | 66,997,569,000 | 62,160,961,000 |
Management Performance
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROIC | 10.17% | 9.16% | 8.49% | 7.96% | 8.13% | 9.08% | 4.83% | 4.55% | 4.93% | 6.01% | 6.02% |
| ROE | 14.67% | 12.90% | 12.67% | 7.50% | 8.32% | 10.27% | 8.07% | 5.98% | 6.04% | 7.06% | 7.62% |
| ROA | 0.00% | 4.55% | 2.24% | 2.11% | 2.17% | 2.26% | 1.73% | 1.57% | 1.52% | 1.72% | 3.64% |
| NM % | 2.26% | 1.95% | 1.94% | 1.80% | 2.02% | 2.13% | 1.61% | 1.39% | 1.30% | 1.38% | 1.43% |
| FCF / R% | 0.00% | 0.59% | 2.84% | 1.53% | 1.91% | 3.55% | 1.57% | 2.03% | 3.51% | 2.97% | 4.59% |
| FCF / NI% | 16.01% | 14.42% | 146.16% | 85.11% | 94.48% | 169.21% | 97.78% | 123.10% | 220.69% | 181.86% | 125.68% |
| Operating Margin (OM) | 0.00 | 0.08 | 0.09 | 0.11 | 0.11 | 0.11 | 0.11 | 0.12 | 0.12 | 0.12 | 0.12 |
Per Share
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | 0.43 | 0.43 | 0.62 | 0.57 | 0.55 | 0.64 | 0.52 | 0.44 | 0.49 | 0.56 | 0.61 |
| SPS | 18.95 | 21.99 | 31.66 | 31.90 | 27.45 | 30.18 | 32.53 | 31.90 | 37.69 | 40.45 | 43.04 |
| OCPS | 0.66 | 0.54 | 1.29 | 0.84 | 0.77 | 1.31 | 0.84 | 1.00 | 1.79 | 1.73 | 2.48 |
| FCPS | 0.18 | 0.13 | 0.90 | 0.49 | 0.52 | 1.07 | 0.51 | 0.65 | 1.32 | 1.20 | 1.98 |
| BVPS | 5.29 | 6.02 | 8.61 | 11.05 | 10.05 | 9.62 | 11.17 | 12.84 | 15.26 | 14.49 | 16.28 |
Per Share - CAGR
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | 0.43 | 0.43 | 0.62 | 0.57 | 0.55 | 0.64 | 0.52 | 0.44 | 0.49 | 0.56 | 0.61 |
| CAGR-SPS | 18.95 | 21.99 | 31.66 | 31.90 | 27.45 | 30.18 | 32.53 | 31.90 | 37.69 | 40.45 | 43.04 |
| CAGR-OCPS | 0.66 | 0.54 | 1.29 | 0.84 | 0.77 | 1.31 | 0.84 | 1.00 | 1.79 | 1.73 | 2.48 |
| CAGR-FCPS | 0.18 | 0.13 | 0.90 | 0.49 | 0.52 | 1.07 | 0.51 | 0.65 | 1.32 | 1.20 | 1.98 |
| CAGR-BVPS | 5.29 | 6.02 | 8.61 | 11.05 | 10.05 | 9.62 | 11.17 | 12.84 | 15.26 | 14.49 | 16.28 |